SynthesisFrontiers in psychiatry2026
Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review.
Synthesis in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Psychedelic-assisted therapy (PAT) is an emerging complex intervention for psychiatric and existential conditions (i.e., forms of distress related to meaning, mortality, and identity, such as that arising in life-threatening illness); however, a systematic characterization of the evaluation methods used across the entire clinical intervention remains incomplete. This scoping review synthesizes the scientific literature on the methodologies and frameworks for evaluating PAT, covering pre-session screening, acute experience, intervention processes, post-session integration, clinical and existential outcomes, safety, and service evaluation. Methods: Following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines, we analyzed 59 peer-reviewed publications, comprising contemporary PAT literature published between 2008 and 2026 and foundational psychometric sources for established instruments used in PAT. The findings were categorized into four evaluation domains: (i) assessment instruments for subjective experiences; (ii) clinical intervention models and competency frameworks; (iii) clinical and existential outcome measures; and (iv) safety, ethics, and implementation frameworks. Results: The analysis reveals a number of advances, including the development and cross-cultural adaptation of validated instruments for measuring mystical and challenging experiences. Clinical intervention frameworks emphasizing the importance of the "therapeutic container" have been articulated, and preliminary work has begun to identify core practitioner competencies. PAT has been associated with preliminary findings from controlled studies for conditions such as depression, anxiety, post-traumatic stress disorder, and existential distress, although demographic representation in trials remains limited, and methodological constraints (e.g., small samples and challenges in blinding) warrant cautious interpretation. The review also identifies gaps: methodological integration is still incomplete, with different assessment domains rarely combined into unified protocols; measures for post-session integration and existential outcomes remain undervalidated; and safety monitoring and implementation science present areas requiring standardization. Discussion: This review maps the current methodological landscape, documenting areas of advancement and defining priorities for developing the integrated, multidimensional evaluation models required to advance the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.